Showing 2,829 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

Antibody-based prevention

Oral tenofovir/FTC increases clearance of bNAb VRC01: implications for future research

Editor's pick
i-Base
4 December 2023
PrEP programmes & uptake

Black Americans still struggle to access PrEP, a medication that could lower HIV rates in the community

Editor's pick
CNN
4 December 2023
Injectable & long-acting PrEP

Follow-Up Study Affirms Efficacy of Injectable Cabotegravir for PrEP, Though Questions Remain on Hypertension, Resistance

Editor's pick
TheBodyPro
4 December 2023
PrEP programmes & uptake

Study identifies barriers that limit young men at HIV risk from taking preventative drug

Editor's pick
EurekAlert!
1 December 2023
Injectable & long-acting PrEP

Long-Acting PrEP in Europe's Fight Against HIV

Editor's pick
Medscape (requires free registration)
1 December 2023
Vaginal rings & topical PrEP

Innovative HIV Prevention Product for Women that Promotes Choice – Dapivirine Vaginal Ring – Gains Momentum Across Africa

Editor's pick
Population Council
30 November 2023
PrEP policies & guidelines

UK: Government ‘exploring’ GP prescribing of HIV PrEP drug

Editor's pick
Pulse
30 November 2023
Injectable & long-acting PrEP

Progress continues to accelerate access to cabotegravir LA for PrEP in low and middle-income countries

Editor's pick
ViiV press release
30 November 2023
Vaginal rings & topical PrEP

South African company to start making vaginal rings that protect against HIV

Editor's pick
Associated Press
30 November 2023
PrEP policies & guidelines

Bending the curve: What a decade-long roll-out of the anti-HIV pill can teach the world

Editor's pick
Bhekisisa
28 November 2023
Pharmaceutical industry

Authorities warn that fake HIV drugs are found in Kenya despite a crackdown on counterfeits

Editor's pick
Associated Press
24 November 2023
PrEP programmes & uptake

Offering PrEP to all pregnant women just as effective as focusing on those at higher risk of HIV

News
21 November 2023
PrEP programmes & uptake

Is on-demand PrEP too demanding? Australian men’s experiences

News
17 November 2023
Finance & funding

Slash the price by three-quarters — South African government on anti-HIV jab

Editor's pick
Bhekisisa
16 November 2023
Global health targets

“Zero chance” of meeting goal of ending HIV transmission among UK gay and bisexual men by 2030

News
16 November 2023
Injectable & long-acting HIV treatment

In-depth: How do long-acting HIV treatments work?

Editor's pick
Spotlight
14 November 2023
Retention & linkage to care

Non-Compliance Isn't the Issue. Systemic Racism Prevents Access to HIV Prevention and Care

Editor's pick
TheBodyPro
13 November 2023
PrEP programmes & uptake

Research Explores Anxiety and Depression Trends in Australians Who Take PrEP

Editor's pick
TheBodyPro
10 November 2023
PrEP policies & guidelines

US to Cover HIV Prevention Drugs for Older Americans to Stem Spread of the Virus

Editor's pick
KFF Health News
8 November 2023
PrEP policies & guidelines

US: The Task Force’s Latest PrEP Recommendation For HIV Is Just More Of The Same

Editor's pick
Health Affairs
6 November 2023
Vaginal rings & topical PrEP

Researchers launch first study of a vaginal film that dissolves in 30 days to assess its acceptability as a potential HIV prevention method for women

Editor's pick
EurekAlert!
2 November 2023
PrEP science

PrEP and sexually transmitted infections A research briefing

About HIV
October 2023
Injectable & long-acting PrEP

Uganda to roll out injectable HIV drug

Editor's pick
Monitor
30 October 2023
PrEP science

Cabotegravir Safe and Effective for Pre-Exposure Prophylaxis in Transgender Women, Global Study Finds

Editor's pick
TheBodyPro
30 October 2023